Rothschild Capital Partners’s Thermo Fisher Scientific TMO Stock Holding History

Rothschild Capital Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,482	Closed	-$728K	–	100
2026 Q1	$728K	Buy	1,482 +1,102	+290%	+$598K	0.18%	52
2025 Q4	$220K	Buy	+380	New	+$215K	0.05%	81
2017 Q4	–	Sell	-1,375	Closed	-$260K	–	54
2017 Q3	$260K	Hold	1,375	–	–	0.11%	50
2017 Q2	$240K	Hold	1,375	–	–	0.09%	45
2017 Q1	$211K	Sell	1,375 -1,375	-50%	-$210K	0.08%	44
2016 Q4	$388K	Hold	2,750	–	–	0.17%	47
2016 Q3	$437K	Hold	2,750	–	–	0.16%	63
2016 Q2	$406K	Hold	2,750	–	–	0.16%	45
2016 Q1	$389K	Hold	2,750	–	–	0.17%	50
2015 Q4	$390K	Hold	2,750	–	–	0.2%	33
2015 Q3	$336K	Hold	2,750	–	–	0.17%	35
2015 Q2	$357K	Sell	2,750 -41,754	-94%	-$5.44M	0.15%	38
2015 Q1	$5.98M	Sell	44,504 -16	-0%	-$2.06K	2.67%	17
2014 Q4	$5.58M	Sell	44,520 -412	-0.9%	-$50.1K	2.68%	17
2014 Q3	$5.47M	Sell	44,932 -28	-0.1%	-$3.4K	2.52%	19
2014 Q2	$5.3M	Hold	44,960	–	–	2.39%	23
2014 Q1	$5.41M	Sell	44,960 -390	-0.9%	-$46.4K	2.66%	20
2013 Q4	$5.05M	Hold	45,350	–	–	2.38%	22
2013 Q3	$4.18M	Buy	45,350 +42,350	+1,412%	+$3.83M	1.97%	26
2013 Q2	$254K	Buy	+3,000	New	+$250K	0.14%	35

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Rothschild Capital Partners's TMO Position: Q2 2026 in Review

Rothschild Capital Partners sold out of Thermo Fisher Scientific (TMO) in Q2 2026, closing a stake of 1,482 shares — an estimated $728K sold.

Rothschild Capital Partners first reported a position in TMO in Q2 2013 and held it in 20 quarters. The position peaked at $5.98M in Q1 2015. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Rothschild Capital Partners reported no remaining Thermo Fisher Scientific position as of Q2 2026 after selling out during the quarter.
Rothschild Capital Partners sold 1,482 Thermo Fisher Scientific shares in Q2 2026, an estimated $728K.
Rothschild Capital Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and held it in 20 quarters.
Rothschild Capital Partners's Thermo Fisher Scientific position peaked at $5.98M in Q1 2015.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Rothschild Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.